共 75 条
[1]
Savarino V(2018)Appropriateness in prescribing PPIs: a position paper of the Italian Society of Gastroenterology (SIGE) - study section “digestive diseases in primary care” Dig Liver Dis 50 894-902
[2]
Tosetti C(2017)Proton-pump inhibitors: understanding the complications and risks Nat Rev Gastroenterol Hepatol 14 697-710
[3]
Benedetto E(2017)Complications of proton pump inhibitor therapy Gastroenterology 153 35-48
[4]
Compare D(2007)Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study Arch Intern Med 167 950-955
[5]
Nardone G(2004)Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs Jama 292 1955-1960
[6]
Malfertheiner P(2012)Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis Am J Gastroenterol 107 507-520
[7]
Kandulski A(2011)Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis CMAJ 183 310-319
[8]
Venerito M(2017)Association of Proton Pump Inhibitors Usage with risk of pneumonia in dementia patients J Am Geriatr Soc 65 1441-1447
[9]
Vaezi MF(2014)Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit JAMA Intern Med 174 564-574
[10]
Yang YX(2016)Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study BMJ 355 i5813-1715